Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
1,072
Views
2
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Letters

Seroprevalence comparison of different varicella vaccines among Turkish children

BongKyoo Choia Department of Research and Development, GC Pharma, Yongin, South Korea;b Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7087-9378View further author information
ORCID Icon &
ShiNae Kwona Department of Research and Development, GC Pharma, Yongin, South KoreaORCID Iconhttps://orcid.org/0000-0002-6464-6965View further author information
ORCID Icon
Article: 2067443 | Published online: 21 Apr 2022

References

  • Umit Z, Sahbudak Bal Z, Zeytinoglu A, Gulbahar Aydogan T, Bag O, Guner Ozenen G, Ozkinay F, Kurugol Z. The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka. Hum Vaccin Immunother. 2021;17(11):4190–2. doi:10.1080/21645515.2021.1967037.
  • Kanra G, Ceyhan M, Ozmert E. Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children. Pediatr Int. 2000;42(6):674–77. doi:10.1046/j.1442-200x.2000.01300.x.
  • Choi UY, Huh DH, Kim JH, Kang JH. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group. Hum Vaccin Immunother. 2016;12(10):2560–64. doi:10.1080/21645515.2016.1190056.
  • Choi UY, Kim KH, Lee J, Eun BW, Kim DH, Ma SH, Kim CS, Lapphra K, Tangsathapornpong A, Kosalaraksa P, et al. Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: a multinational, multicenter, randomized, double-blinded, active-controlled phase III study. Vaccine. 2021;39(12):1758–64. doi:10.1016/j.vaccine.2021.02.013.
  • Williams V, Gershon A, Brunell PA. Serologic response to Varicella-Zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis. 1974;130(6):669–72. doi:10.1093/infdis/130.6.669.
  • Sauerbrei A, Färber I, Brandstädt A, Schacke M, Wutzler P. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test. J Virol Methods. 2004;119(1):25–30. doi:10.1016/j.jviromet.2004.02.012.
  • Winsnes R, Wiger D. The potency determination of human varicella-zoster immunoglobulin by enzyme-linked immunosorbent assay, complement-fixation test and indirect fluorescent antibody tests. J Biol Stand. 1986;14(4):351–61. doi:10.1016/0092-1157(86)90023-5.
  • Larussa P, Steinberg S, Waithe E, Hanna B, Holzman R. Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test. J Clin Microbiol. 1987;25(11):2059–62. doi:10.1128/jcm.25.11.2059-2062.1987.
  • Lee YH, Choe YJ, Cho SI, Kang CR, Bang JH, Oh MD, Lee JK. Effectiveness of Varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016;31(12):1897–901. doi:10.3346/jkms.2016.31.12.1897.
  • Lee YH, Choe YJ, Cho SI, Bang JH, Oh MD, Lee JK. Increasing varicella incidence rates among children in the Republic of Korea: an age-period-cohort analysis. Epidemiol Infect. 2019;147:e245. doi:10.1017/S0950268819001389.
  • Choi B, Shin JH, Lee JE, Koh S. Letter to the editor: epidemiological comments on the effectiveness of the Varicella vaccine in Korea. J Korean Med Sci. 2020;35(28):e265. doi:10.3346/jkms.2020.35.e265.
  • Choi B, Shin JH, Lee JE, Koh SB. Letter to the editor: effectiveness of the Varicella vaccine in Korea: unresolved issues. J Korean Med Sci. 2021;36(27):e200. doi:10.3346/jkms.2021.36.e200.
  • Choi B, Cho H, Shin Y, Lee EK. Letter to the editor: effectiveness of the Varicella vaccine among Korean children: suggestions for future research. J Korean Med Sci. 2022;37(1):e17. doi:10.3346/jkms.2022.37.e17.
  • Hong K, Sohn S, Choe YJ, Rhie K, Lee JK, Han MS, Chun BC, Choi EH. Waning effectiveness of one-dose Universal Varicella vaccination in Korea, 2011-2018: a propensity score matched national population cohort. J Korean Med Sci. 2021;36(36):e222. doi:10.3346/jkms.2021.36.e222.
  • Choi JK, Park SH, Park S, Choi SM, Kim SH, Lee DG, Yoo JH, Choi JH, Kang JH. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015. Hum Vaccin Immunother. 2019;15(11):2554–60. doi:10.1080/21645515.2019.1603985.
  • Jung J, Ko YJ, Kim YE, Huh K, Park BJ, Yoon SJ. Epidemiological impact of the Korean National Immunization Program on varicella incidence. J Korean Med Sci. 2019;34(7):e53. doi:10.3346/jkms.2019.34.e53.
  • Cho H, Sun E, Jeong S, Ann S, Choi B Trends in the incidence of varicella cases with complications among Korean children during 2010-2020 after the universal one-dose varicella vaccination program. Submitted (under review) to the 2022 International Conference on Pharmacoepidemiology, August 24-28, 2022, Copenhagen, Denmark.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.